BRIEF published on 03/09/2026 at 18:00, 3 months 16 days ago Information sur les droits de vote de Roche Bobois Droits De Vote Actions Auto-détenues Roche Bobois Ameublement Haut De Gamme Résultats Financiers 2025
PRESS RELEASE published on 03/09/2026 at 17:55, 3 months 16 days ago INFORMATION MENSUELLE RELATIVE AUX DROITS DE VOTE Informations financières et corporatives sur ROCHE BOBOIS SA : détails des actions et droits de vote, présentation de l'entreprise et de ses marques, chiffre d'affaires 2025 Chiffre D'affaires Droits De Vote Actions Roche Bobois Entreprise Familiale
BRIEF published on 02/18/2026 at 17:55, 4 months 7 days ago Roche Bobois : Mise à jour des droits de vote au 31 janvier 2026 Droits De Vote Actions AMF Transparence Financière Roche Bobois
BRIEF published on 02/18/2026 at 17:55, 4 months 7 days ago Roche Bobois: Update of voting rights as of January 31, 2026 Voting Rights Actions AMF Financial Transparency Roche Bobois
PRESS RELEASE published on 02/18/2026 at 17:50, 4 months 7 days ago INFORMATION MENSUELLE RELATIVE AUX DROITS DE VOTE Communiqué de presse sur Roche Bobois SA, entreprise familiale française fondée en 1960, présente dans 56 pays. Chiffre d'affaires consolidé en 2025 : 402,5 M€ Chiffre D'affaires Roche Bobois Entreprise Familiale French Art De Vivre Créations Originales
BRIEF published on 02/16/2026 at 17:55, 4 months 9 days ago Roche Bobois: Share Buyback from February 9 to 13, 2026 Euronext Share Buyback Purchase Price Roche Bobois February 2026
BRIEF published on 02/16/2026 at 17:55, 4 months 9 days ago Roche Bobois : Rachat d'Actions du 9 au 13 Février 2026 Rachat D'actions Euronext Roche Bobois Prix D'acquisition Février 2026
PRESS RELEASE published on 02/16/2026 at 17:50, 4 months 9 days ago RACHAT D'ACTIONS PROPRES DU 9 AU 13 FEVRIER Roche Bobois SA effectue des transactions dans le cadre de son programme de rachat d'actions propres autorisé par l'AG du 12 juin 2025 Transactions Rachat D'actions Propres Assemblée Générale Programme Roche Bobois SA
BRIEF published on 02/10/2026 at 18:05, 4 months 15 days ago Roche Bobois continues its share buyback program Euronext Share Buyback Capital Structure Roche Bobois Authorized Program
BRIEF published on 02/10/2026 at 18:05, 4 months 15 days ago Roche Bobois poursuit son programme de rachat d'actions Rachat D'actions Euronext Structure De Capital Roche Bobois Programme Autorisé
Published on 06/26/2026 at 14:05, 2 hours 56 minutes ago SouthGobi Announces Voting Results of Annual General Meeting of Shareholders
Published on 06/26/2026 at 14:00, 3 hours 1 minute ago Dateline Chairman Invests $1.95 million through Options Exercise
Published on 06/26/2026 at 13:00, 4 hours 1 minute ago Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 12:45, 4 hours 16 minutes ago Northern Dynasty Reports Oral Arguments Held
Published on 06/26/2026 at 15:30, 1 hour 30 minutes ago JMGO Extends Special Savings Beyond Prime Day with N3 Ultimate at Its Best Price Since Launch
Published on 06/26/2026 at 15:23, 1 hour 37 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 06/26/2026 at 15:23, 1 hour 37 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 06/26/2026 at 15:22, 1 hour 38 minutes ago Form 8.3 - The Vanguard Group, Inc.: Senior plc
Published on 06/26/2026 at 07:00, 10 hours 1 minute ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 10 hours 1 minute ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
